Jaguar Health announced that Napo Therapeutics, the corporation Jaguar established in Italy in 2021 that focuses on expanding access to the Company’s oral botanical drug crofelemer for orphan and rare diseases in Europe, is a Platinum Sponsor of the 9th Annual Elite Ped-GI Congress, which takes place May 4-6, 2023 in Abu Dhabi in the United Arab Emirates.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on JAGX:
- Jaguar Health announces results of survey of U.S. veterinary oncologists
- Jaguar Health says patient enrollment surpasses 90% in Phase 3 OnTarget trial
- Jaguar Health provides update on possible illegal short selling
- Jaguar Health reports 2022 EPS ($36.18) vs. ($88.22) last year
- Jaguar Health appoints Kelly Shanahan to Scientific Advisory Board
